Federation des caisses Desjardins du Quebec’s Edesa Biotech EDSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-19
Closed -$85 2580
2024
Q3
$85 Hold
19
﹤0.01% 2499
2024
Q2
$81 Hold
19
﹤0.01% 2390
2024
Q1
$80 Hold
19
﹤0.01% 2340
2023
Q4
$87 Hold
19
﹤0.01% 2303
2023
Q3
$85 Hold
19
﹤0.01% 2319
2023
Q2
$109 Hold
19
﹤0.01% 2270
2023
Q1
$123 Hold
19
﹤0.01% 2276
2022
Q4
$292 Hold
19
﹤0.01% 2381
2022
Q3
$124 Hold
19
﹤0.01% 2457
2022
Q2
$217 Hold
19
﹤0.01% 2483
2022
Q1
$401 Hold
19
﹤0.01% 2484
2021
Q4
$760 Hold
19
﹤0.01% 2441
2021
Q3
$996 Hold
19
﹤0.01% 2456
2021
Q2
$713 Hold
19
﹤0.01% 2453
2021
Q1
$729 Buy
+19
New +$766 ﹤0.01% 2385

Other funds holding EDSA

Federation des caisses Desjardins du Quebec's EDSA Position: Q4 2024 in Review

Federation des caisses Desjardins du Quebec sold out of Edesa Biotech (EDSA) in Q4 2024, closing a stake of 19 shares — an estimated $85 sold.

Federation des caisses Desjardins du Quebec first reported a position in EDSA in Q1 2021 and held it in 15 quarters. The position peaked at $996 in Q3 2021. 17 funds tracked by Wall St. Rank hold EDSA as of Q4 2024.

  • Federation des caisses Desjardins du Quebec reported no remaining Edesa Biotech position as of Q4 2024 after selling out during the quarter.
  • Federation des caisses Desjardins du Quebec sold 19 Edesa Biotech shares in Q4 2024, an estimated $85.
  • Federation des caisses Desjardins du Quebec first reported a position in Edesa Biotech in Q1 2021 and held it in 15 quarters.
  • Federation des caisses Desjardins du Quebec's Edesa Biotech position peaked at $996 in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Edesa Biotech as of Q4 2024.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q4 2024, filed 14 Feb 2025.